ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,245,005 | +128.1% | 18,864 | +241.6% | 0.00% | – |
| Q2 2023 | $984,143 | -62.9% | 5,523 | -65.7% | 0.00% | -100.0% |
| Q1 2023 | $2,653,547 | -7.7% | 16,086 | -11.9% | 0.00% | 0.0% |
| Q4 2022 | $2,876,215 | -58.0% | 18,264 | -59.8% | 0.00% | -66.7% |
| Q3 2022 | $6,846,000 | -36.2% | 45,460 | -30.3% | 0.00% | -25.0% |
| Q2 2022 | $10,728,000 | -30.9% | 65,257 | -6.4% | 0.00% | -20.0% |
| Q1 2022 | $15,524,000 | -13.9% | 69,729 | -8.3% | 0.01% | 0.0% |
| Q4 2021 | $18,040,000 | +27.9% | 76,009 | +25.7% | 0.01% | +25.0% |
| Q3 2021 | $14,109,000 | +360.5% | 60,457 | +306.1% | 0.00% | +300.0% |
| Q2 2021 | $3,064,000 | +28.7% | 14,888 | +28.5% | 0.00% | 0.0% |
| Q1 2021 | $2,381,000 | -16.3% | 11,590 | -12.6% | 0.00% | 0.0% |
| Q4 2020 | $2,844,000 | +10.8% | 13,261 | -5.6% | 0.00% | 0.0% |
| Q3 2020 | $2,567,000 | +107.7% | 14,045 | +109.5% | 0.00% | 0.0% |
| Q2 2020 | $1,236,000 | -42.5% | 6,705 | -37.1% | 0.00% | 0.0% |
| Q1 2020 | $2,151,000 | -57.2% | 10,662 | -60.3% | 0.00% | -50.0% |
| Q4 2019 | $5,020,000 | -1.9% | 26,831 | -16.3% | 0.00% | 0.0% |
| Q3 2019 | $5,117,000 | +50.0% | 32,057 | +136.8% | 0.00% | +100.0% |
| Q2 2019 | $3,411,000 | -30.6% | 13,539 | -34.1% | 0.00% | -50.0% |
| Q1 2019 | $4,918,000 | +11.3% | 20,549 | +6.8% | 0.00% | 0.0% |
| Q4 2018 | $4,417,000 | -44.6% | 19,233 | -31.8% | 0.00% | -33.3% |
| Q3 2018 | $7,979,000 | +15.9% | 28,216 | +20.3% | 0.00% | 0.0% |
| Q2 2018 | $6,887,000 | +102.3% | 23,454 | +73.9% | 0.00% | +200.0% |
| Q1 2018 | $3,405,000 | -37.2% | 13,490 | -46.3% | 0.00% | -50.0% |
| Q4 2017 | $5,423,000 | +88.2% | 25,105 | +62.0% | 0.00% | +100.0% |
| Q3 2017 | $2,881,000 | +20.9% | 15,499 | +12.2% | 0.00% | 0.0% |
| Q2 2017 | $2,383,000 | +19.1% | 13,810 | +5.4% | 0.00% | 0.0% |
| Q1 2017 | $2,001,000 | -6.8% | 13,102 | -10.0% | 0.00% | 0.0% |
| Q4 2016 | $2,147,000 | +28.6% | 14,564 | +10.2% | 0.00% | 0.0% |
| Q3 2016 | $1,670,000 | +18.1% | 13,213 | +5.4% | 0.00% | 0.0% |
| Q2 2016 | $1,414,000 | +8.3% | 12,536 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $1,306,000 | -11.8% | 12,549 | -4.4% | 0.00% | 0.0% |
| Q4 2015 | $1,480,000 | -27.9% | 13,128 | -30.0% | 0.00% | 0.0% |
| Q3 2015 | $2,053,000 | +33.6% | 18,755 | +16.7% | 0.00% | 0.0% |
| Q2 2015 | $1,537,000 | -22.3% | 16,066 | -24.3% | 0.00% | 0.0% |
| Q1 2015 | $1,977,000 | +90.3% | 21,219 | +67.2% | 0.00% | 0.0% |
| Q4 2014 | $1,039,000 | – | 12,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |